IBO Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Impact Biomedical Inc (IBO) is not a strong buy at the moment for a beginner investor with a long-term strategy. The lack of positive financial performance, absence of strong trading signals, and neutral sentiment from hedge funds and insiders suggest limited upside potential. The technical indicators also do not support a compelling entry point.
The MACD histogram is negative (-0.00165) and contracting, indicating bearish momentum. RSI is neutral at 42.438, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its pivot level (0.429), with resistance at 0.471 and support at 0.387. Overall, the technical indicators suggest a bearish trend.
NULL identified. No recent news or significant trading trends from hedge funds or insiders.
The company's financial performance is weak, with a significant YoY decline in net income (-134.61%) and EPS (-300.00%). Gross margin remains negative (-1505.56). No recent positive sentiment or trading activity from influential figures or institutions.
In Q3 2025, revenue remained flat at 18,000 (0.00% YoY). Net income dropped significantly to -1,470,000 (-134.61% YoY), and EPS fell to -0.12 (-300.00% YoY). Gross margin is negative at -1505.56, showing no improvement.
No data available for analyst ratings or price target changes.
